STMicroelectronics Releases Prototype Design of Disposable Insulin Nanopump
Release date: 2008-06-30 STMicroelectronics Announces Prototype Design of Disposable Insulin Nanopumps Debiotech and STMicroelectronics recently released the first prototype of a miniature insulin infusion pump. This micro device can be installed on a disposable applicator to continuously deliver insulin injections to patients. Diabetes patients are more likely to get drugs, and the treatment efficiency and quality of life have been greatly improved. This innovative nanopump is based on microfluidic MEMS technology and has successfully passed the initial testing phase and is now in production preparation. Shine Skin Pumpkin Seed,Bulk Pumpkin Seeds,Bulk Dried Pumpkin Seeds,Shine Skin Pumpkin Seeds NINGXIA HONG RISING BIOLOGICAL TECHNOLOGY CO.,LTD. , https://www.hongrisinggoji.com
This highly miniaturized disposable insulin syringe pump combines Debiotech's insulin infusion system technology with ST's microfluidic MEMS chip's mass production capabilities. The nanopump is only one-fourth the size of an existing insulin pump and can be mounted on an almost invisible applicator.
Microfluidic technology can also better control the injection volume of insulin solution, more accurately imitate the process of naturally secreting insulin from islets, and also detect possible malfunctions of the pump to better protect patients' safety.
In addition, this MEMS-based nano syringe pump is very inexpensive as a disposable product manufactured using large-scale semiconductor technology. As a result, patients or healthcare systems will not have to afford the upfront investment common to existing syringe pump solutions.
Insulin pump therapy or continuous subcutaneous injection of insulin (CSII) can replace a single insulin injection that must be infused several times a day. This treatment is becoming more and more popular. According to the CSII treatment, the diabetic patient is connected to a programmable syringe pump. The syringe pump is connected to a reservoir, and insulin is infused from the reservoir into the subcutaneous tissue of the human body. During the infusion process of one day, according to the patient's Set the amount of liquid. The insulin injection pump, developed by Debiotech and industrialized by ST, marks the first application of microfluidic MEMS technology to the treatment of diabetes.
“The initial trial of the revolutionary insulin nanopump prototype has been a success and has taken another step towards commercialization,†said Benedetto Vigna, vice president of the STMicroelectronics division and general manager of MEMS, healthcare equipment, RF transceivers and sensor products. By partnering with our main partner, Debiotech, we will introduce a small micro silicon product that will make a significant difference in the lives of millions of people worldwide."
“This is a milestone in the industrialization of insulin nanopumps. It is a major achievement in the emergence of a new type of drug injection equipment. The new infusion equipment combines the highest reliability and performance, bringing unprecedented convenience and safety to patients. Sex," said Dr. Frédéric Neftel, President and CEO of Debiotech. "Our cooperation with ST is very successful, both in terms of timeliness and achievement. This allows us to focus on finding a leading medical device company now. Establish long-term partnerships and bring our products to market.†——Shanghai Medical Device Industry Association website